You are using an outdated browser. Please upgrade your browser to improve your experience.

chloroquine

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. In March 2020, FDA issued an emergency use authorization (EUA) for hydroxychloroquine and chloroquine in the treatment of COVID-10. EUA was revoked in June 2020. Data from various published randomized, controlled clinical trials and retrospective, cohort studies have not substantiated initial reports of efficacy of 4-aminoquinoline antimalarials for treatment of COVID-19.
Synonyms & Links
PubChem: 2719
Guide to Pharmacology: 5535
DrugCentral: 607
LyCHI:  4P9RDYHQL13F


Target Activities